Alvimopan is a peptide compound that functions as a peripherally restricted opioid receptor antagonist, designed to block opioid effects in the gastrointestinal tract without affecting central nervous system activity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 156053-89-3
Dexketoprofen trometamol
pharmaceutical raw material
Rupatadine trihydrochloride
pharmaceutical raw material
Cisplatin
pharmaceutical raw material
N-nitroso-clozapine
pharmaceutical raw material
Ent-Alvimopan
pharmaceutical intermediate
(2S,3S,4S)-Alvimopan
pharmaceutical raw material
(2R,3R,4R)-Alvimopan
pharmaceutical raw material
N-[(2S)-2-{[(3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl}-3-(²H₅)phenylpropanoyl]glycine
pharmaceutical raw material
2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid
UPNUIXSCZBYVBB-JVFUWBCBSA-N
C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O